Medtronic Foresees Gradual ICD Uptake, Reviews Battery Problem

Demand for Medtronic's implantable cardioverter defibrillators in response to CMS' January coverage decision will increase gradually over the next several quarters rather than in one dramatic surge, according to the company

More from Archive

More from Medtech Insight